Startup Develops Self-Monitoring Medical Device
Omaha startup, Centese, is a medtech company that has developed the Thoraguard. This innovative medical device is self-cleaning, self-irrigating, and self-monitoring. Through the self-monitoring function, it only alerts medical staff if it measures an excess amount of post-surgical fluid drainage, meaning hospital staff can be doing other important tasks without needing to keep a constant lookout for blockages. The device will tell staff if there are blockages, other problems like irregularities, and even leaks in the system in order to avoid complications.
The Thoraguard brings new technology to one that has remained nearly unchanged for 70 years. The current method of measuring post-surgical fluid drain is by looking at it and physically marking the container with a pen, which can be highly inaccurate. The Thoraguard will save money, time, and provide better patient care as it can more accurately monitor and provide measurements of patient’s conditions after surgery.
Are you developing new medical technology? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.